Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
337,298
Value
$18.9M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of RPRX by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026337,298$18.9M<0.1%+193,538+134.6%AddedHolders
Q1 2026143,760$6.90M<0.1%+129,816+931.0%AddedHolders
Q4 202513,944$538.8K<0.1%+2,129+18.0%AddedHolders
Q3 202511,815$416.8K<0.1%−798−6.3%ReducedHolders
Q2 202512,613$454.5K<0.1%+526+4.4%AddedHolders
Q1 202512,087$376.3K<0.1%−2,742−18.5%ReducedHolders
Q4 202414,829$378.3K<0.1%−14,499−49.4%ReducedHolders
Q3 202429,328$829.7K<0.1%−1,596−5.2%ReducedHolders
Q2 202430,924$815.5K<0.1%−2,535−7.6%ReducedHolders
Q1 202433,459$1.02M<0.1%−5,589−14.3%ReducedHolders
Q4 202339,048$1.10M<0.1%−17,872−31.4%ReducedHolders
Q3 202356,920$1.54M<0.1%−4,745−7.7%ReducedHolders
Q2 202361,665$1.90M<0.1%+260.0%AddedHolders
Q1 202361,639$2.22M<0.1%−3,999−6.1%ReducedHolders
Q4 202265,638$2.59M<0.1%+1,484+2.3%AddedHolders
Q3 202264,154$2.58M<0.1%+63,866+22,175.7%AddedHolders
Q2 2022288$12.0K<0.1%+29+11.2%AddedHolders
Q1 2022259$10.0K<0.1%+112+76.2%AddedHolders
Q4 2021147$6.00K<0.1%−60−29.0%ReducedHolders
Q3 2021207$7.00K<0.1%+200+2,857.1%AddedHolders
Q2 20217$00.0%+7NewHolders